$ZS

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.

Original reporting
Published Oct 7, 2026, 4:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 5:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ZS
Bullish
high confidence
Mentioned
$ZS
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ZSBullishMed
01

Why it matters

The upgrade provides a fresh catalyst that could attract short‑term buying, but insider sell activity tempers enthusiasm.

02

Market read

First report of a price‑target increase for Zscaler; likely to generate modest price movement.

03

What to watch

Recent insider selling of $6.4 M could signal internal concerns despite the rating lift.

Relevance 7/10Novelty 6/10Timing: intraday today

Background

Barclays raised Zscaler's price target from $220 to $225 and kept an Overweight stance, citing growth in its zero‑trust platform.

Company-level read

Ticker impact

$ZSBullishHigh confidence
Context

Barclays maintained Overweight on Zscaler and raised its price target to $225, a fresh analyst upgrade.

Expected impact

modest upside as investors price in the higher target

Evidence & confidence

The upgrade is the first report of a price‑target increase; such moves typically generate buying pressure.

Market effects

May boost sentiment for the broader cybersecurity/software sector.

Limited to U.S. tech equities.

Minor, confined to investors tracking analyst upgrades.

Counterpoint

The upgrade may be premature given Zscaler's unprofitability and high P/S ratio.

Key entities

  • Barclays

    Maintained Overweight and raised price target for Zscaler.

  • Zscaler Inc.

    Cybersecurity firm receiving the rating upgrade.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSHigh

RBC Capital maintains Zscaler stock rating on $8B ARR target

RBC Capital reiterated an Outperform rating and $236.00 price target on Zscaler (ZS) after the company's Investor Day, where it set an $8B ARR target for 2031. The stock trades at $210.94, and analysts have raised earnings estimates. Several firms increased price targets, with Cantor Fitzgerald setting the highest at $275.